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Abstract: Synthetic biology offers potential for innovation in the agrifood sector, although concerns have been raised consumer rejection of 
applications will occur similar to that associated with the introduction of genetically modified foods. Risk-benefit assessment should address 
socio-economic, as well as health and environmental impacts. Ethical issues may be of particular relevance to the application synthetic biol-
ogy, and may also resonate with societal concerns. A case-by-case analysis of relevant issues may be needed, and innovation must be driven 
by societal and consumer preferences as well as technological possibilities. Research into consumer and societal priorities is required early 
in the innovation trajectory. 
Introduction 
There has been recent discussion regarding the potential 
for synthetic biology applications to deliver benefits across a 
range of application areas, including those within the agrifood 
sector (e.g. Moe-Behrens et al.., 2013). At the same time, the 
evolving regulatory and governance environment is currently 
shifting from one that emphasises precautionary approaches 
and risk avoidance, to one that encourages socially responsible 
research and innovation, such that science and technology is 
steered towards societally approved and, indeed, preferred 
outcomes (Douglas & Stemerding, 2014). In common with 
regulatory relevant elements of other enabling technologies, 
such as nanotechnology, there is no standardised definition of 
the term “synthetic biology”, (Synthetic Biology Org, 2014; 
Cogem, 2013; Rerimassie & Stemerding, 2012), although 
there is consensus that it represents the convergence of 
biotechnology (in particular GM [genetic modification]) 
and systems engineering (Andrianantoandro et al.., 2006; 
Purnick & Weiss, 2009). A defining element which unites 
various definitions is that synthetic biology represents “the 
design and construction of novel artificial biological pathways, 
organisms or devices, or the redesign of existing natural 
biological systems” (UK Royal Society, 2014). In other words, 
the goal of synthetic biology is to synthesis artificial and 
natural components to form new artificial living systems. The 
inclusion of artificial DNA in the process, as well as broad 
claims, including within the media that synthetic biology is 
“creating life” (Gibson et al.., 2008), has focused societal 
speculation on the ethical issues associated with the technology 
(e.g. BBC, 2010). In practice, however, it is important to note 
that the potential range of applications available for use in 
the short term remains more prosaic (Kitney & Freemont, 
2012), and it is long term future developments which are the 
object of speculation (Kaiser, 2012; Vincent, 2013). Indeed, 
Bubela et al. (2012, p.132) have noted that “maintaining the 
trust of the public and policy regulators is paramount….Hype 
and exaggerated claims are counterproductive to developing 
adaptive and ethically sound regulatory models responsive to 
stakeholder concerns”. These authors argue that developing 
ethical frameworks is necessary to develop public trust in 
regulation and governance, as well as ensuring effective 
application and commercialisation of products, not least within 
the agrifood sector. 
Examples of potential areas of application to the 
agrifood sector 
The application of synthetic biology offers considerable 
potential for generating innovation in the area of agricultural 
production and food. Potential future applications include 
bioremediation (e.g. see Brenner et al.., 2008; Lovely, 2003), 
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developments of healthier foods, (e.g. though increasing the 
lycopene and b-carotene contents of fruit and vegetables, 
Fraser et al..,  2009), improving food safety (e.g. through 
bacterial detection (OECD 7 Royal Society, 2010), the 
production of metabolites and health-related products such 
as vitamins, nutraceuticals and probiotics (e.g. see Curran and 
Alpes, 2012; Fraser et al..,  2009; OECD &Royal Society, 
2010), production of improved preservatives (OECD & Royal 
Society, 2010), flavours and flagrance biosensors (e.g. see 
Urlacher & Eiben, 2006), and food waste processing (OECD 
& Royal Society, 2010). Synthetic biology in some ways can 
be described as representing an “evolution” of GM, albeit 
one which is described as a convergence with engineering 
applications, rather than a completely novel technology. This 
may not align with media representations of synthetic biology, 
where it is sometimes represented as novel, and separate from 
previous technological innovations (Bubela et al., 2012).
Potential drivers of societal responses to synthetic 
biology applied in the agri-food sector
Societal responses to the application of synthetic biology 
may distinguish between “top-down” and “bottom up” 
applications (e.g. see Bedau et al., 2009). As is the case for 
the definition of synthetic biology per se, a range of definitions 
of what constitutes “top down” and “bottom up” synthetic 
biology are available. Broadly, “top down” is generally 
regarded as being initiated from a pre-existing natural living 
system which is then re-engineered to obtain a specific goal 
(Ro et al., 2006), through genome synthesis (e.g. Gibson et 
al., 2008), or genome transplantation (Lartigue et al., 2007). 
“Bottom up” synthetic biology attempts to develop minimal 
chemical cellular life (or “protocells”) from inanimate raw 
ingredients (Rasmussen et al., 2008). The latter is less 
developed scientifically compared to the former. There has 
been speculation that it is “bottom-up” synthetic biology 
which will be the primary focus of societal risk perceptions, 
negativity and ethical concerns (Cranor, 2009). However, while 
the distinction between top-down and bottom-up synthetic 
biology is likely to represent a relevant distinction as far as 
regulation, governance and ethical debate are concerned, 
similar differentiation in societal debate and public acceptance 
may be less clear-cut, as many of the same issues (for example, 
the creation of “artificial life”) may be perceived to be relevant 
in both contexts (but see Bedau et al., 2009). It should be noted 
that a defining factor of the “protocell” is that the chemical 
system can adapt to changing environments and therefore has 
reproductive potential  (Rasmussen et al., 2009b), which in 
turn implies that natural selection might result in unintended, 
and potentially uncontrollable, new life forms. The ability of 
an artificial living organism to reproduce and exist outside 
of contained facilities may be perceived to have irreversible 
impacts on human and animal health, and the environment. 
This perception, in turn, may be associated with negative 
affective (or emotional) responses on the part of the public, 
which will result in consumer rejection of specific products. 
Such an effect has been observed for various potential hazards 
(Slovic et al., 2004). In addition, factors such as perceptions 
of unnaturalness, and in some cases religious concerns, may 
influence societal acceptance of synthetic biology and its 
applications. Research has shown that these factors have been 
drivers of societal negativity associated with GM foods (e.g. 
see Frewer et al., 2013a; Gaskell et al., 1999). 
As a consequence of synthetic biology both having 
parallels with the application of GM technology in food 
and agriculture, and potentially raising additional issues of 
societal concern, there has been speculation that synthetic 
biology will be associated with a similar level of societal 
rejection to that associated with GM technologies (e.g. see 
Torgersen, 2009). Within the range of areas of application of 
GM technologies, GM applications linked to food production 
are judged by society to be the most controversial (e.g. see 
Costa-Font et al., 2006; Dannenberg, 2009; Frewer et al., 
2013a). It might therefore be expected that, in discussions 
regarding the potential application of synthetic biology to 
different areas, its application to food and agriculture might be 
the area of application construed most negatively by the public 
(Philp et al.., 2013; Torgersen & Schmidt, 2013). However, 
it can also be argued that the GM foods controversy should 
not necessarily automatically be regarded as a “normative” 
societal response to all agrifood innovations, as context and 
(perceived) product characteristics have, to a large extent, 
shaped societal responses to GM foods (e.g. see Frewer et al., 
2011; Mehta, 2004). In addition, research into people’s risk 
perceptions has tended to focus on high profile and dramatic 
potential hazards at the expense of low profile and familiar 
ones (Hawkes & Rowe, 2008). In reality, consumer acceptance 
of novel products is likely to depend on the extent to which 
potential consumers perceive there is a benefit associated 
with the new product, and the extent to which perceived 
benefit is weighed against perceived risk (e.g. Brown & Ping, 
2003; Frewer et al. 2003; Gupta et al., 2012; Poinhos et al., 
accepted; Ueland et al., 2012). Both the perceived risks and 
perceived benefits associated with different products produced 
using different emerging enabling technologies is likely to 
vary between individuals, and will be influenced by cultural 
and socio-demographic factors. Socio-economic impacts (for 
example, negative or positive effects on employment, industrial 
competiveness, or national and regional competiveness) also 
need to be assessed (see e.g. Frewer, 1013b; Mora et al., 2012)
As well as making comparisons between the agrifood 
application of Synthetic biology and the introduction of GM 
foods, it is also relevant to draw a parallel with societal 
responses to nanotechnology (including application to 
agri-food production), where the lack of negative societal 
response has characterised early commercial introductions, 
despite predictions that societal rejection of nanotechnology 
applications would occur (Torgersen; 2009). In this case, 
expert concerns about negative societal responses to agrifood 
nanotechnology (e.g. see Gupta et al., 2013) have not been 
matched, to date, by concern-based societal debate (Torgersen 
& Schmidt, 2013; Philp et al., 2013), despite NGO opposition 
to agri-food nanotechnology applications (e.g. Friends of the 
Earth, 2014), and requirements for more rigid regulation 
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associated with their application (AAAS, 2014). Frewer et al. 
(2014) have speculated that the lack of consumer opposition 
to nanotechnology as currently observed may be attributable 
to the following. First, innovative technological innovation 
applied to food production per se is not societally unacceptable. 
Rather (perceived) characteristics of specific technologies, or 
their application, or how these are regulated, may potentially 
be drivers of societal negativity (see also Frewer et al., 2011). 
Second, it may be too early in the implementation trajectory 
for societal negativity associated with specific applications 
of agrifood nanotechnology to have arisen, as consumers are 
not familiar with either nanotechnology or its application 
within the areas of agriculture or the human food chain. 
Third, lessons from the application of GM food technologies 
have been implemented by regulators and industry in the 
case of nanotechnology, which has resulted in increased 
acceptance of agrifood applications by consumers (see also 
Gupta, 2013). These issues will now be considered in the 
current analysis, and recommendations for the introduction 
and commercialisation of synthetic biology in agrifood sector 
will be developed. 
First, if specific characteristics of technologies applied to 
agriculture and food production drive consumer responses, it is 
important to identify what consumers perceive to be associated 
with both risk and benefit of different applications of emerging 
technologies. Other values or attitudes will also shape peoples 
intention to adopt specific applications. For example, the 
extent to which people perceive a particular product, or 
the technology used to produce it, to be unnatural, or have 
ethical concerns about technology (see Costa-Font et al., 2008; 
Frewer et al., 2013a). Similar concerns have not arisen in 
association with agrifood applications of nanotechnology per 
se, but appear to focus on specific areas of application. For 
example, the acceptability of smart pesticides is focused on the 
issue of pesticide use rather than the issue of nanotechnology 
being used to develop pesticides (Gupta, 2013). The area 
of application should be considered when introducing the 
initial applications of agrifood synthetic biology, to ensure 
that these early applications deliver concrete and tangible 
benefits, in which the benefits perceived to be available to 
(at least some) consumers outweigh perceived risks. This 
raises the question of whether high levels of risk perception 
associated with GM was driven by concerns related to (for 
example) irreversibility of negative biological effects once 
released into the environment, such as the ability to confer 
“unnatural” traits on “descendant” organisms (Torgersen, 
2009; Frewer et al., 2011). In comparison, nanotechnology 
may be perceived to be less uncontrollable and potentially 
amenable to mitigation strategies should problems occur. It 
might be predicted that synthetic biology will be perceived 
as being more similar to GM than to nanotechnology, given 
that living organisms are being manipulated (Bubela et al., 
2012; Pauwels, 2013).  
The second argument, that it is too early in the 
implementation trajectory for consumer attitudes towards 
specific applications of both agrifood nanotechnology 
and synthetic biology to have crystallized, is potentially 
valid (Frewer et al., 2014). However, given that labelled 
nanotechnology consumer products are apparently accepted by 
many consumers who use them (e.g. in the cosmetics sector, 
DeLouise, 2012), it is reasonable to posit that societal rejection 
of nanotechnology per se will not occur. It is important to 
note that there has not been the same level of media coverage 
of either nanotechnology or synthetic biology applied to 
agrifood production when compared to the levels of media 
attention associated with GM foods (e.g. see Pidgeon et al., 
2003; Frewer et al., 2002; Pauwels & Ifrim (2008), or even 
nanotechnology (Scheufele, et al., 2007). The occurrence 
of a negative, high profile media associated with a specific 
enabling technology might ignite societal controversy if it 
has extensive media coverage (Gupta et al., accepted). It is 
suggested that synthetic biology may be particularly prone to 
sensational media reporting, as previously discussed. 
The third argument, that lessons learned from the 
commercialisation of agrifood GM have been applied to the 
introduction of nanotechnology, and may potentially be applied 
to synthetic biology, is also worthy of further consideration. 
The introduction of GM foods was not shaped by information 
about societal requirements for technological implementation, 
but rather driven by technological possibilities. However, 
the 21st century has witnessed the introduction of various 
policy changes associated with technological innovation which 
have built on, and attempted to remediate, the barriers to 
agrifood technology implementation associated with the latter 
part of the 20th century. For example, the need to assess 
socio-economic and ethical impacts associated with different 
applications of enabling technologies has been recognised by 
various researchers and is frequently embedded in in policy 
(e.g.Rerimassie & Stemerding, 2012). The need for effective 
stakeholder, expert and public inputs into the research and 
development, commercialisation and policy process has also 
been identified as a factor facilitating acceptance of technology 
applications (e.g. Powell & Colin, 2008; Renn &Roco; 2006). 
More recently, there has been a greater likelihood of public 
engagement being applied prior to technological introductions, 
rather than subsequent to their application (MacNaghten, 
et al.., 2005; Delgado et al.., 2011). The consideration of 
a broader range of expertise in assessing different policy 
options might lead to better outcomes as more evidence 
(lay knowledge, perceptions, and preferences) is considered 
formally as part of decision-making (Reed 2008; Renn & 
Roco, 2006). For example, nanotechnology was successfully 
introduced to the public through a number of participatory 
events, which addressed concerns and problems raised by both 
experts and ordinary citizens (Torgersen &Schmidt 2013). 
Thus, public engagement can provide a route to enhance 
mutual understanding of technological issues, uncertainties 
associated with risk and benefit assessments, as well as value 
differences in different stakeholder constituencies (Dietz, 
2012). 
However, public engagement is unlikely to build societal 
trust in technology development and implementation if the 
outputs of such exercises do not make a discernable impact on 
policy in policy, regulation, and even product design. The lack 
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of policy impact associated with public engagement has indeed 
been recognised as problematic (Emery et al., , in press; 
PytlikZillig and Tomkins, 2011). Others (e.g. Kenyon, 2005) 
have noted the lack of generalizability of results from specific 
engagement exercises, which tend to focus on limited areas 
of application, across a broad policy issue. It is important to 
balance the interest and values of all relevant stakeholders 
(Hermans et al., 2012), and develop methods to assure timely 
incorporation of stakeholder perspectives into the decision-
making process associated with synthetic biology policy 
development (OECD & Royal Society, 2010). 
Ethical issues 
As for other technologies, (see, for example, Coles & 
Frewer, 2013; Jensen et al., 2011), it is possible to identify 
generic and specific ethical issues which may influence 
both the technological development and commercialisation 
trajectories associated with synthetic biology. For example, 
the application of an Ethical Matrix analysis (Mepham, 2000) 
to synthetic biology applied to food production would enable 
a range of ethical issues to be assessed against the needs 
of different stakeholder groups, including basic scientists, 
technology developers, industry, consumers, and the 
environment. Very broadly, the ethical principles of autonomy 
(“self-determination”), non-malfeasance (to “do no harm”), 
beneficence (“do good”) and justice (“fairness”) can be 
applied to different stakeholders. While this has limitations 
in analysing and weighing the ethical issues associated with 
a technology, it is helpful in identifying the types of issues 
that may need to be considered (Schroeder & Palmer, 2003). 
Synthetic biology may raise specific issues intrinsically 
related to the characteristics of synthetic biology (Deplazes-
Zemp, 2012), insomuch as the design and synthesis of living 
organisms may lead to specific responsibilities on the part of 
scientists regarding the products they are developing. It may 
therefore be important to take these concerns into discussions 
regarding science and technology policies, possibly as a 
formal part of the analysis which precedes the enactment of 
regulation. 
Regulatory issues 
Synthetic biology, as for other areas of biotechnology, 
may have both positive and negative impacts, depending on 
how it is applied, and societal judgements of what constitutes 
positive or negative application. It has been argued  that the 
current framework for regulation of laboratory research 
and development of commercial biotechnology products can 
serve as a basis for regulation of synthetic biology (see, inter 
alia, Erickson et al., 2011; Rerimassie & Stemerding, 2012). 
However, inter-regional differences in regulatory application 
have been associated with the regulation of biotechnology, 
in particular GM technologies (Vàzquez-Salat et al., 2012), 
which have not facilitated societal trust in the regulatory 
process (Frewer et al., 2013b). In addition, some of the 
ethical issues associated with the development of artificial, 
self-producing organisms may entail formal additional ethical 
assessment as part of the risk analysis process which informs 
regulatory decision-making and governance practices.
Consumer research 
Published research in this area is sparse, which may reflect 
the fact that technological developments are comparatively 
recent. Given that biotechnology may represent an important 
benchmark against which synthetic biology is being evaluated 
by the public (Kronberger et al., 2009), one might predict 
similar societal concerns to arise in the agrifood sector. Pauwels 
(2009) notes that, the participants in their US study reported 
being unfamiliar with synthetic biology and its applications, 
their perceptions and related attitudes were framed by those 
they already held about existing biotechnologies such as 
GM and cloning (Pauwels, 2013). Furthermore, participants 
were positive about synthetic biology applications when 
these addressed societal, medical, and sustainability needs. 
Similarly, concerns arose if credible assessments of potential 
risks, uncertainties associated with these, and long-term 
implications were not made. Transparency and accountability 
through “tailored governance” (i.e. governance focused on 
specific issues associated with synthetic biology, in particular 
risks, benefits, and ethical issues) was required by participants. 
Ethical or moral impacts associated with the technology and 
its applications were reported as relevant in several studies. 
For example, research using Malaysian stakeholders (Amin et 
al., 2011) has identified ethical concerns to be associated with 
genetically modified (GM) rice which contains a synthetic 
mouse gene to increase its vitamin C content. At the same 
time, the loss of benefits from not developing the application 
were perceived to be inconsequential. 
In summary, various questions need to be asked of 
synthetic biology prior to, and during, the commercialisation 
process associated with the agrifood sector. These are similar 
to those applied in other sectors although some issues specific 
to synthetic biology can be identified. •• Do the applications to the agrifood sector meet a recog-
nised societal need? (see also Gupta et al., 2012)•• Can similarities between synthetic biology applied in 
the agrifood sector, and potentially societally contro-
versial aspects of previously applied agrifood technolo-
gies be identified? (see also Frewer et al., 2011; 2014).•• Is agrifood application of the technology differently 
perceived by the public to other areas of application, 
such as pharmaceutical application? (Frewer et al., 
2013a). In other words, is it the area of application, 
rather than the technology per se, which is associated 
with societal negativity? (Gupta et al., accepted). •• Are alternative, less controversial, technological ap-
proaches, which have potential to deliver the same 
benefits, identifiable? (Gupta et al., 2013). •• Are additional issues raised over and above those asso-
ciated with other enabling technologies applied to food 
production? For example, are there specific ethical is-
sues associated with synthetic biology which are not as-
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sociated with the application of nanotechnology? (e.g. 
see Cranor, 2009). •• If the technology is, in itself, acceptable to society, 
what needs to be done to “fine tune” the development 
and implementation of agrifood applications of synthet-
ic biology to align with consumer priorities for com-
mercialisation of specific applications? (e.g. see Raley 
et al., submitted). •• Are there specific features of the regulatory frame-
work which are required to ensure societal acceptance 
of specific applications (for example, formal and insti-
tutionalised ethical analysis and socioeconomic impact 
analysis)? (e.g. see Bubela et al., 2012). 
An important part of implementing a societally acceptable 
development and commercialisation trajectory in particular 
in relation to synthetic biology applications which are 
potentially societally controversial (for example, application 
in the agrifood sector), will require inclusion of societal 
priorities and preferences for specific benefits to be included 
in the design of new applications. There are many ways to 
collate this information. Examples include public engagement 
regarding the development, implementation and governance 
of the technology during development, and qualitative and 
quantitative consumer research which can be applied to 
“fine-tuning the characteristics of specific applications. 
This will require closer engagement and communication 
between scientists, technologists and those with expertise in 
assessing societal and consumer preferences and priorities 
for technology and product design. In terms of regulation 
and governance, it is important to ensure that the outputs of 
public engagement are explicitly addressed in the development 
of regulatory and governance strategies if social trust in 
these is to be developed and maintained. In terms of the 
development of concrete products, research has suggested 
that the need to consider information regarding societal and 
consumer preferences would be most relevant prior to new 
product development and prior to any marketing activities 
being operationalized, as there is still time to alter the design 
and delivery of novel foods and processes. It may also be 
important to assess consumer responses to the first generation 
of synthetic biology products developed, in order to predict 
what features of second generation products are most likely 
to be successful. In other words, it is important to understand 
what applications are most wanted by consumers, and which 
are unacceptable. This could contribute to an application 
based risk(benefit) framework,  The development of these 
principles is a consequence of lesson from the GM debate, and 
can be adapted to take account of specific characteristics of 
synthetic biology. This speaks to the third question identified 
in the introduction, namely that “lessons from the application 
of GM food technologies have been implemented in the case 
of nanotechnology, which can subsequently be applied to 
agrifood applications of synthetic biology”. Synthetic biology 
may be regarded as an acceptable technology by society, if 
appropriate societal benefits are delivered from its application, 
ethical issues are addressed, and transparent regulatory and 
governance structures are constructed. Rather than it being 
“too early” in the process of synthetic biology development 
for public opinions and attitudes to crystallise, we suggest that 
this is the most appropriate point in the development trajectory 
to utilise public and consumer information in the development 
and design of agrifood synthetic biology applications. 
Conclusions
The successful implementation of synthetic biology in 
the agrifood sector will be contingent on various factors. 
These include the development applications (in particular first 
generation consumer products) that society and consumers 
want, and regard as safe. Given the potentially diverse range 
of applications, assessment of societal and consumer priorities 
need to be on a case by case basis. Risk-benefit assessment 
should be an integral part of governance, and address socio-
economic impacts as well as health and environmental effects. 
Ethical issues may be of particular relevance to the application 
of synthetic biology, and may also resonate with societal 
concerns. Again a case-by-case analysis of relevant risk 
and ethical issues may be needed. Societal and consumer 
acceptance of agrifood applications of synthetic biology 
is likely to be driven by perceptions that applications are 
needed, but hindered by lack of public debate about risk, 
benefit and unintended effects, and the failure to establish 
and adequate regulatory framework to promote consumer and 
environmental protection. 
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